secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2025-01-10T23:59:59+00:00
Accession:  0001104659-25-002198
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel corrects board appointment error in Securities Purchase Agreement with David Lazar
--------------------------------------------------------------------------------

- Addendum corrects inadvertent error: Mr. Lazar was not appointed as Board member or Chairman, only has right to appoint one director.
- David Natan appointed as designee of Lazar and chairman of audit committee.
- Amendment restates Section 2.3(a)(v) to reflect correct intent regarding board appointment and resolutions.
- All other terms of the Purchase Agreement remain unchanged and in full force and effect.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000110465925002198/0001104659-25-002198-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000110465925002198/tm252869d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-002198

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer